STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the initiation of the first clinical sites in Europe in collaboration with GEICAM in Spain. The Company has partnered with GEICAM, the largest academic breast cancer research network in Spa
For patients with schizophrenia spectrum disorders, implementing conventional nutritional education strategies and specific nutritional advice with a symbiotic effect improves dietary-nutritional profiles.
For patients with schizophrenia spectrum disorders, implementing conventional nutritional education strategies and specific nutritional advice with a symbiotic effect improves dietary-nutritional profiles.
Noozhawk.com delivers local breaking news, local sports, schools, nonprofits, obituaries, business, arts and entertainment, calendar, local opinions and more.
Health Impairment in Spondyloarthritis Associated With High Disease Activity, Worsening Functionality, and Concomitant Fibromyalgia rheumatologyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rheumatologyadvisor.com Daily Mail and Mail on Sunday newspapers.